State RI
Clinical Trials in Rhode Island
Recruiting clinical trials with at least one study location in Rhode Island. Data updated daily from ClinicalTrials.gov.
Top Conditions in Rhode Island
NCT06409975 N/A
Recruiting
Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and N...
Condition
Healthy
Enrollment
50 pts
Location
United States
Sponsor
University of Rhode Island
NCT06998069 Phase 3
Recruiting
Head and Neck Cancer Study Project in the Geriatric Population
Condition
Head and Neck Neoplasms
Enrollment
20 pts
Location
United States
Sponsor
Brown University
NCT06636786 Phase 2
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Subli...
Condition
Acute Stress Reaction
Enrollment
180 pts
Location
United States
Sponsor
University of North Carolina,
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
250 pts
Location
United States
Sponsor
University of California, San
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT06316830 Phase 2, Phase 3
Recruiting
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and P...
Condition
Opioid Use Disorder
Enrollment
250 pts
Location
United States
Sponsor
Rhode Island Hospital
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT06584357 N/A
Recruiting
Development of a Database to Investigate Digital and Blood-Based Biomarkers and ...
Condition
Mild Cognitive Impairment
Enrollment
1,200 pts
Location
United States, Canada, United Kingdom
Sponsor
GAP Innovations, PBC
NCT06370520 N/A
Recruiting
Screening Emotions in Adolescents at the Hospital for mTBI
Condition
Brain Injury Traumatic Mild
Enrollment
2,592 pts
Location
United States
Sponsor
University of California, Davi
NCT06988306 N/A
Recruiting
Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
Condition
Diabetes Mellitus
Enrollment
978 pts
Location
United States
Sponsor
California Polytechnic State U
NCT03507257 N/A
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Condition
Early Onset Alzheimer Disease
Enrollment
850 pts
Location
United States, Argentina, Netherlands
Sponsor
Indiana University
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
540 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT06673303 N/A
Recruiting
Investigating The Role of Noise Correlations in Learning
Condition
Noise Correlations
Enrollment
40 pts
Location
United States
Sponsor
Brown University
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory...
Condition
Neuroblastoma
Enrollment
104 pts
Location
United States, Canada
Sponsor
Milton S. Hershey Medical Cent
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06822569 N/A
Recruiting
Teen Health Choices & Wellness
Condition
Health Behavior
Enrollment
224 pts
Location
United States
Sponsor
Brown University
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI